Intranasal delivery of mesenchymal stem cell‐derived exosomes reduces oxidative stress and markedly inhibits ethanol consumption and post‐deprivation relapse drinking. (21st September 2018)

• Record Type: Journal Article
• Authors: Ezquer, Fernando; Quintanilla, María Elena; Morales, Paola; Santapau, Daniela; Ezquer, Marcelo; Kogan, Marcelo J.; Salas‐Huenuleo, Edison; Herrera‐Marschitz, Mario; Israel, Yedy
• Is Part Of: Addiction biology. Volume 24:Number 5(2019)
• Page Start: 994
• Page End: 1007
• Publication Date: 2018-09-21
• Subjects: ADE -- binge‐drinking -- exosomes -- GLT‐1 -- mesenchymal stem cells -- non‐invasive; Substance abuse -- Periodicals; Substance abuse -- Physiological aspects -- Periodicals; Substance-Related Disorders -- periodicals; 616.86
• DOI: 10.1111/adb.12675
• Languages: English
• ISSNs: 1355-6215

Abstract

Abstract: Chronic ethanol consumption leads to brain oxidative stress and neuroinflammation, conditions known to potentiate and perpetuate each other. Several studies have shown that neuroinflammation results in increases in chronic ethanol consumption. Recent reports showed that the intra‐cerebroventricular administration of mesenchymal stem cells to rats consuming alcohol chronically markedly inhibited oxidative‐stress, abolished neuroinflammation and greatly reduced chronic alcohol intake and post deprivation relapse‐like alcohol intake. However, the intra‐cerebroventricular administration of living cells is not suitable as a treatment of a chronic condition. The present study aimed at inhibiting ethanol intake by the non‐invasive intranasal administration of human mesenchymal stem cell products: exosomes, microvesicles (40 to 150 nm) with marked antioxidant activity extruded from mesenchymal stem cells. The exosome membrane can fuse with the plasma membrane of cells in different tissues, thus delivering their content intracellularly. The study showed that the weekly intranasal administration of mesenchymal stem cell‐derived exosomes to rats consuming alcohol chronically (1) inhibited their ethanol intake by 84 percent and blunted the relapse‐like 'binge' drinking that follows an alcohol deprivation period and ethanol re‐access. (2) Intranasally administered exosomes were found in the brain within 24 hours; (3) fully reversed both alcohol‐induced hippocampal oxidative‐stress, evidenced by a lower ratio of oxidized to reduced glutathione, and neuroinflammation, shown by a reduced astrocyte activation and microglial density; and (4) increased glutamate transporter GLT1 expression in nucleus accumbens, counteracting the inhibition of glutamate transporter activity, reportedly depressed under oxidative‐stress conditions. Possible translational implications are envisaged. Abstract : Intranasal noninvasive administration of human mesenchymal stem cell exosomes markedly inhibits (80–85 percent) chronic ethanol intake by alcohol‐preferring rats and fully reversed ethanol‐induced oxidative stress and neuroinflammation. Exosomes also inhibited (50–60 percent) relapse binge‐drinking following chronic ethanol intake, deprivation and ethanol reaccess.